Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration.
Joel HanhartRony WienerHashem TotahEvgeny GelmanYishay WeillAdi AbulafiaDavid ZadokPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2022)
Delay in timely retinal care during the COVID-19 restrictions period resulted in short-term negative outcomes, including macular bleeding, in nvAMD patients.
Keyphrases
- age related macular degeneration
- vascular endothelial growth factor
- end stage renal disease
- diabetic retinopathy
- optical coherence tomography
- coronavirus disease
- sars cov
- newly diagnosed
- healthcare
- ejection fraction
- endothelial cells
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- atrial fibrillation
- quality improvement
- type diabetes
- patient reported outcomes
- pain management
- ultrasound guided
- insulin resistance